Insulet | PODD - 普通股股本



金融业
股票价格
USD
资产
USD 3.19B
现金及等价物
USD 716.1M
销售成本
USD 215.2M
流动资产
USD 1.91B
流动负债
USD 680.1M
债务
USD 1.01B
EBIT
USD 146.3M
EBITDA
USD 194M
员工
3.9K
EPS每股收益
USD 1.44
股本和储备
USD 1.52B
销售毛利
USD 568.6M
债务利息支出
USD 9.2M
利息收入
USD 8.6M
贷款资金
USD 930.8M
市值
USD 11.98B
净收入
USD 101.6M
营业费用
USD 637.5M
营业利润
USD 146.3M
普通股股本
USD 70.35M
PE价格收益
55.08
税前利润
USD 140.2M
销售收入
USD 783.8M
销售和管理费用
USD 331.4M
股票
USD 452.6M
贸易债权人
USD 75M
应收帐款人
USD 516.9M


普通股股本 更改 日
Abbott USD 1.74B 23.39B 2025-09
Align Technology USD 71.62M 133K 2026-03
AtriCure USD 49.79M 91K 2025-12
Avanos Medical USD 46.46M 39.46K 2025-12
Baxter International USD 516.45M 2.17M 2026-03
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Boston Scientific USD 1.48B 2.66M 2025-12
Cardinal Health USD 235M 1000K 2026-03
Cooper Companies USD 195.1M 3.71M 2025-12
Dexcom USD 385.9M 1.1M 2026-03
Edwards Lifesciences USD 580.7M 0 2025-12
Eli Lilly USD 943.5M 3.33M 2026-03
Globus Medical USD 135.06M 449K 2025-12
ICU Medical USD 24.69M 2K 2025-12
Inogen USD 23K 0 2023-12
Insulet USD 70.35M 1000 2025-12
Integra LifeSciences USD 77.89M 34K 2025-12
J&J USD 2.41B 1.74M 2025-12
Masimo USD 52.1M 1000K 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Merit Medical Systems USD 59.65M 231K 2026-03
Roche Holding CHF 795.62M 699.54K 2025-12
Solventum Corp USD 173.49M 51.34K 2025-12
Stryker USD 382.98M 584K 2026-03
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teleflex USD 44.19M 1000 2025-12
West Pharmaceutical Services USD 70.9M 1.1M 2026-03
Zimmer Biomet Holdings USD 195.5M 2.68M 2026-03